MakCHS Publications

Found 341 results
Author [ Keyword(Desc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Adolescent
D. Serwadda, Gray, R. H., Sewankambo, N. K., Wabwire-Mangen, F., Chen, M. Z., Quinn, T. C., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Ashley Morrow, R., and Wawer, M. J., Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda., The Journal of infectious diseases, vol. 188, no. 10, pp. 1492-7, 2003.
G. Kigozi, Gray, R. H., Wawer, M. J., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chen, M. Z., Sewankambo, N. K., Wabwire-Mangen, F., Bacon, M. C., Ridzon, R., Opendi, P., Sempijja, V., Settuba, A., Buwembo, D., Kiggundu, V., Anyokorit, M., Nkale, J., Kighoma, N., and Charvat, B., The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda., PLoS medicine, vol. 5, no. 6, p. e116, 2008.
G. Kigozi, Gray, R. H., Wawer, M. J., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chen, M. Z., Sewankambo, N. K., Wabwire-Mangen, F., Bacon, M. C., Ridzon, R., Opendi, P., Sempijja, V., Settuba, A., Buwembo, D., Kiggundu, V., Anyokorit, M., Nkale, J., Kighoma, N., and Charvat, B., The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda., PLoS medicine, vol. 5, no. 6, p. e116, 2008.
R. H. Gray, Kiwanuka, N., Quinn, T. C., Sewankambo, N. K., Serwadda, D., Mangen, F. W., Lutalo, T., Nalugoda, F., Kelly, R., Meehan, M., Chen, M. Z., Li, C., and Wawer, M. J., Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team., AIDS (London, England), vol. 14, no. 15, pp. 2371-81, 2000.
M. A. Eller, Blom, K. G., Gonzalez, V. D., Eller, L. A., Naluyima, P., Laeyendecker, O., Quinn, T. C., Kiwanuka, N., Serwadda, D., Sewankambo, N. K., Tasseneetrithep, B., Wawer, M. J., Gray, R. H., Marovich, M. A., Michael, N. L., de Souza, M. S., Wabwire-Mangen, F., Robb, M. L., Currier, J. R., and Sandberg, J. K., Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans., PloS one, vol. 6, no. 4, p. e18779, 2011.
Adult
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
G. Kigozi, Gray, R. H., Wawer, M. J., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chen, M. Z., Sewankambo, N. K., Wabwire-Mangen, F., Bacon, M. C., Ridzon, R., Opendi, P., Sempijja, V., Settuba, A., Buwembo, D., Kiggundu, V., Anyokorit, M., Nkale, J., Kighoma, N., and Charvat, B., The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda., PLoS medicine, vol. 5, no. 6, p. e116, 2008.
A. D. Redd, Dabitao, D., Bream, J. H., Charvat, B., Laeyendecker, O., Kiwanuka, N., Lutalo, T., Kigozi, G., Tobian, A. A. R., Gamiel, J., Neal, J. D., Oliver, A. E., Margolick, J. B., Sewankambo, N., Reynolds, S. J., Wawer, M. J., Serwadda, D., Gray, R. H., and Quinn, T. C., Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa., Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 16, pp. 6718-23, 2009.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
C. L. Cooper and Cameron, W. D., Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection., AIDS (London, England), vol. 18, no. 2, pp. 337-8, 2004.
D. Serwadda, Gray, R. H., Sewankambo, N. K., Wabwire-Mangen, F., Chen, M. Z., Quinn, T. C., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Ashley Morrow, R., and Wawer, M. J., Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda., The Journal of infectious diseases, vol. 188, no. 10, pp. 1492-7, 2003.
G. Chamie, Wandera, B., Marquez, C., Kato-Maeda, M., Kamya, M. R., Havlir, D. V., and Charlebois, E. D., Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach., Trop Med Int Health, vol. 20, no. 4, pp. 537-45, 2015.
C. L. Cooper and Cameron, W. D., Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection., AIDS (London, England), vol. 18, no. 2, pp. 337-8, 2004.
C. Kigonya, Lutwama, F., and Colebunders, R., Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (HIV)-seropositive African woman., International journal of dermatology, vol. 47, no. 1, pp. 102-3, 2008.
G. Chamie, Wandera, B., Marquez, C., Kato-Maeda, M., Kamya, M. R., Havlir, D. V., and Charlebois, E. D., Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach., Trop Med Int Health, vol. 20, no. 4, pp. 537-45, 2015.
R. H. Gray, Kiwanuka, N., Quinn, T. C., Sewankambo, N. K., Serwadda, D., Mangen, F. W., Lutalo, T., Nalugoda, F., Kelly, R., Meehan, M., Chen, M. Z., Li, C., and Wawer, M. J., Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team., AIDS (London, England), vol. 14, no. 15, pp. 2371-81, 2000.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
B. Castelnuovo, Manabe, Y. C., Kiragga, A., Kamya, M., Easterbrook, P., and Kambugu, A., Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 49, no. 6, pp. 965-72, 2009.
G. Kigozi, Gray, R. H., Wawer, M. J., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chen, M. Z., Sewankambo, N. K., Wabwire-Mangen, F., Bacon, M. C., Ridzon, R., Opendi, P., Sempijja, V., Settuba, A., Buwembo, D., Kiggundu, V., Anyokorit, M., Nkale, J., Kighoma, N., and Charvat, B., The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda., PLoS medicine, vol. 5, no. 6, p. e116, 2008.
M. A. Eller, Blom, K. G., Gonzalez, V. D., Eller, L. A., Naluyima, P., Laeyendecker, O., Quinn, T. C., Kiwanuka, N., Serwadda, D., Sewankambo, N. K., Tasseneetrithep, B., Wawer, M. J., Gray, R. H., Marovich, M. A., Michael, N. L., de Souza, M. S., Wabwire-Mangen, F., Robb, M. L., Currier, J. R., and Sandberg, J. K., Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans., PloS one, vol. 6, no. 4, p. e18779, 2011.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
Anti-HIV Agents
J. Kagaayi, Dreyfuss, M. L., Kigozi, G., Chen, M. Z., Wabwire-Mangen, F., Serwadda, D., Wawer, M. J., Sewankambo, N. K., Nalugoda, F., Kiwanuka, N., Kiddugavu, M., and Gray, R. H., Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 39, no. 1, pp. 121-4, 2005.
R. Colebunders, Moses, K. R., Laurence, J., Shihab, H. M., Semitala, F., Lutwama, F., Bakeera-Kitaka, S., Lynen, L., Spacek, L., Reynolds, S. J., Quinn, T. C., Viner, B., and Mayanja-Kizza, H., A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries., The Lancet infectious diseases, vol. 6, no. 1, pp. 53-9, 2006.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
C. Kigonya, Lutwama, F., and Colebunders, R., Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (HIV)-seropositive African woman., International journal of dermatology, vol. 47, no. 1, pp. 102-3, 2008.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
B. Castelnuovo, Nanyonjo, A., Kamya, M., and Ocama, P., Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?, African health sciences, vol. 8, no. 2, pp. 133-4, 2008.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
Antiretroviral Therapy, Highly Active
C. L. Cooper and Cameron, W. D., Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection., AIDS (London, England), vol. 18, no. 2, pp. 337-8, 2004.
C. L. Cooper and Cameron, W. D., Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection., AIDS (London, England), vol. 18, no. 2, pp. 337-8, 2004.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
R. Colebunders, Moses, K. R., Laurence, J., Shihab, H. M., Semitala, F., Lutwama, F., Bakeera-Kitaka, S., Lynen, L., Spacek, L., Reynolds, S. J., Quinn, T. C., Viner, B., and Mayanja-Kizza, H., A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries., The Lancet infectious diseases, vol. 6, no. 1, pp. 53-9, 2006.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.

Pages